Tapestry, Inc. vs Zoetis Inc — how do they compare? Tapestry, Inc. trades at $153.47 (market cap $32.44B), while Zoetis Inc trades at $72.44 (market cap $31.14B). The key difference: Tapestry, Inc. and Zoetis Inc are close in size by market cap, and Zoetis Inc pays the higher dividend (2.81%). Which is the better fit depends on your goals.
| TPR | ZTS | |
|---|---|---|
Market Cap | $32.44B | $31.14B |
Sector | Consumer Cyclical | Health |
52-Week High | $164.78 | $156.76 |
52-Week Low | $95.69 | $71.91 |
Enterprise Value | $35.29B | $38.70B |
Dividend Yield | 1% | 2.81% |
Signals from Pluang's Aura AI — not financial advice
TPR trades at $164.78, up 1.49% with strong technical momentum and bullish moving averages. The company has consistently beaten earnings expectations in recent quarters, with Q1 2026 EPS of $1.66 exceeding the $1.30 estimate. Analyst sentiment remains overwhelmingly positive with 31 buy ratings and a $190.33 consensus price target, representing 15.5% upside potential. Recent news highlights Tapestry's AI initiatives and strong brand momentum driving market share gains.
The outlook appears favorable given TPR's earnings beat streak and positive analyst coverage, though elevated valuation ratios (P/E 48.95, P/S 4.34) and recent net income margin compression from 12.23% to 2.61% warrant monitoring. Key risks include competitive pressures in luxury retail and potential macroeconomic headwinds affecting consumer spending.
Zoetis (ZTS) trades at $74.86, up 3.03% today but facing bearish technical signals with 16 sell indicators. The company reported mixed Q2 2026 results, beating EPS estimates but missing revenue expectations, while cutting full-year guidance due to softer pet healthcare demand. Strong fundamentals include a 27.69% net margin and 64.91% ROE, though valuation metrics show a P/E of 12.29 and P/S of 3.41.
The stock presents a value opportunity with analyst consensus target of $94.90 (27% upside), but faces near-term headwinds from competitive pressures and class action lawsuits. Investors should weigh strong profitability against slowing growth in companion animal segments and technical bearishness.
Trailing returns across standard periods
Coach, Kate Spade, and Stuart Weitzman are the fashion and accessory brands that comprise Tapestry. The firm's products are sold through about 1,400 company-operated stores, wholesale channels, and e-commerce in North America (67% of fiscal 2022 sales), Europe, Asia (28% of fiscal 2022 sales), and elsewhere. Coach (74% of fiscal 2022 sales) is best known for affordable luxury leather products. Kate Spade (22% of fiscal 2022 sales) is known for colorful patterns and graphics. Women's handbags and accessories produced 69% of Tapestry's sales in fiscal 2022. Stuart Weitzman, Tapestry's smallest brand, generates nearly all its revenue from women's footwear.
Read more on TPR →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →